Yale Cancer Center — New Haven, Connecticut

Yale Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Yale Cancer Center has participated in 298 clinical trials with 111 currently active.

Therapeutic areas: Advanced Head and Neck Squamous Cell Carcinoma, Urothelial Cancer, Lymphoma, Solid Tumor.

Sponsors: Celldex Therapeutics, Astellas Pharma Global Development, Inc., Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale Cancer Center?

Yale Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale Cancer Center conducted?

Yale Cancer Center has 298 clinical trials on record, with 111 currently active. Their work covers Advanced Head and Neck Squamous Cell Carcinoma, Urothelial Cancer, Lymphoma, Solid Tumor.

Is Yale Cancer Center accredited by Crixeo Health?

Yale Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.